Cardiovascular Risk Reduction and LDL-C

Learn about LDL-cholesterol, its relationship to CVD, and the role of non-statin therapies in management from clinical lipid specialists.

Lipid Management, Pharmacology
Member Cost: $0
Credits: 1.0 CE contact hours, 0.5 CE pharmacology hours

Course Overview

Register

Evolving Perspectives in Lipid Management

Learn about LDL-cholesterol, its relationship to CVD, and the role of non-statin therapies in management from clinical lipid specialists. Case study examples include clinical pearls, making the presentation easily applicable to a variety of practice settings.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Increased awareness of recent evidence further supporting the relationship between lowering LDL-C and ASCVD risk.]
  • Implementation of updated, recommended algorithms for LDL-lowering with non-statin therapies to further reduce ASCVD risk.
  • Increased attainment of LDL-C treatment goals in vulnerable patient populations.
  • Greater confidence in utilizing nonstatin therapies that lower LDL-C well below current targets and demonstrate net ASCVD risk-reduction benefit.

Faculty

  • Margo Minissian, PhDc, ACNP-BC, CLS-BC, CNS, AACC, FAHA
  • Robert Giugliano, MD, MSc